In This Article:
As global markets show signs of optimism with cooling inflation and robust bank earnings propelling stocks higher, investors are keenly observing the performance of value stocks, particularly in sectors like energy and financials. In this environment, dividend stocks become an attractive option for those seeking steady income streams, as they can offer stability and potential growth even amidst fluctuating economic conditions.
Top 10 Dividend Stocks
| Name | Dividend Yield | Dividend Rating |
| Tsubakimoto Chain (TSE:6371) | 4.30% | ★★★★★★ |
| Wuliangye YibinLtd (SZSE:000858) | 3.63% | ★★★★★★ |
| CAC Holdings (TSE:4725) | 4.69% | ★★★★★★ |
| Southside Bancshares (NYSE:SBSI) | 4.54% | ★★★★★★ |
| Yamato Kogyo (TSE:5444) | 4.08% | ★★★★★★ |
| GakkyushaLtd (TSE:9769) | 4.44% | ★★★★★★ |
| China South Publishing & Media Group (SHSE:601098) | 4.12% | ★★★★★★ |
| Guangxi LiuYao Group (SHSE:603368) | 3.49% | ★★★★★★ |
| Nihon Parkerizing (TSE:4095) | 4.01% | ★★★★★★ |
| DoshishaLtd (TSE:7483) | 3.89% | ★★★★★★ |
Click here to see the full list of 1983 stocks from our Top Dividend Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Consun Pharmaceutical Group
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Consun Pharmaceutical Group Limited is engaged in the research, development, manufacturing, and sale of Chinese medicines and medical contrast medium products in the People’s Republic of China, with a market cap of HK$6.52 billion.
Operations: Consun Pharmaceutical Group Limited's revenue is comprised of CN¥2.33 billion from the Consun Pharmaceutical Segment and CN¥410 million from the Yulin Pharmaceutical Segment.
Dividend Yield: 7.4%
Consun Pharmaceutical Group's dividend payments are covered by both earnings and cash flows, with payout ratios of 52.3% and 54% respectively. While dividends have grown over the past decade, they have been volatile with significant annual drops. The stock trades at a good value compared to peers and industry standards but offers a lower yield than top-tier Hong Kong dividend payers. Recent amendments to company bylaws could impact future governance or strategy decisions.
Daicel
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Daicel Corporation operates in materials, medical/healthcare, smart, safety, and engineering plastics sectors across Japan, China, and internationally with a market cap of approximately ¥367.56 billion.
Operations: Daicel Corporation's revenue segments include the Material Business at ¥195.47 billion, Engineering Plastics Business at ¥242.85 billion, Safety Business at ¥95.51 billion, Smart Business at ¥35.82 billion, and Medical/Healthcare at ¥14.24 billion.